[Effect of moxibustion on small intestinal mucosal immune barrier in rats with diarrhea-predominant irritable bowel syndrome].

Researchers studied whether moxibustion, a traditional Chinese medicine therapy using heated herbs, could help relieve symptoms of irritable bowel syndrome with diarrhea (IBS-D). They created an IBS-D model in laboratory rats and then treated one group with moxibustion at two acupuncture points on the abdomen and leg (Tianshu/ST25 and Shangjuxu/ST37) for 20 minutes daily over seven days. The treated rats showed significant improvements compared to untreated rats with IBS-D. Their body weight increased, diarrhea decreased, and their pain sensitivity improved. When researchers examined the small intestine under microscopes, they found that moxibustion helped repair damaged tissue. The intestinal lining became healthier, with longer villi (finger-like projections that absorb nutrients) and better-organized cells. The treatment also balanced immune system markers that were previously disturbed, including reducing inflammation-related proteins and improving protective antibodies. The tight connections between intestinal cells, which act as barriers against harmful substances, showed partial recovery. These findings suggest moxibustion may help IBS-D patients by repairing the intestinal immune barrier and reducing gut hypersensitivity. This could explain why some patients experience relief from abdominal pain and diarrhea with this therapy. While these are animal study results and human responses may differ, the research provides biological evidence for how moxibustion might work. If you're considering moxibustion for digestive issues, consult with a qualified, licensed acupuncturist who can assess whether this treatment is appropriate for your specific condition.

This study investigated moxibustion's effects on small intestinal mucosal immune barriers in IBS-D model rats (n=24 in treatment/model groups, n=12 controls). The IBS-D model was induced through neonatal maternal separation, acetic acid enema, and chronic restraint stress. Suspending moxibustion at bilateral ST25 and ST37 (20 min/day for 7 days) significantly improved multiple parameters compared to model controls (P<0.01 for most measures). Results included reduced loose stool rate, increased pain threshold (AWR scoring), improved duodenal villus length and villus-to-crypt ratio, and increased goblet cell counts. Treatment normalized T-cell subset ratios (decreased CD4+/CD8+), reduced inflammatory cytokines (IFN-γ, IL-4) and sIgA levels, and decreased intraepithelial lymphocyte infiltration. Electron microscopy revealed partial restoration of epithelial cell tight junctions and improved mucosal integrity. Clinical implication: Moxibustion at ST25/ST37 may reduce visceral hypersensitivity and IBS-D symptoms through small intestinal immune barrier repair and immunomodulation.